Staff Data Search - جامعة الزقازيق

/ Staff Data Search - جامعة الزقازيق

رشا محمد مصطفى حجاج

Personal Website

Rasha Mohamed Mostafa Hagag

Faculty Medicine - Department Oncology

Scientific degrees

BSc In , [1998]
MSc In NULL, [2004]
(Study of serum vascylar endothelial growth factor and vascular cell adhesion molecule in metasttic breast cancer and response to weekly docetaxel protocol/)

الحالة الوظيفية الحالية :

قائم بالعمل

Academic Jobs

معيد : 3/5/2003
Doctor Assisant : 25/8/2004
Doctor : 27/10/2010
Professor Assisant : 26/11/2015
Professor : 29/12/2020

Publications

1 - نمط الوفيات الناجمة عن السرطان في مستشفى رعاية ثالثية سعودي (2012).

2 - نمط الصفات الاكلينيكيه و الباثولوجيه و معدل بقاء مرضى سرطان القولون و المستقيم صغار السن: تجربه من غرب المملكه العربيه السعوديه (2013).

3 - تأثيــر السمية الكبدية الناتجة عن العلاج الكيماوى المناعى على حصيلة مرضى سرطان الخلايا اللمفــاوية البائية المتوسعة السائبة المصابين بالإلتهاب الكبدى الفيروسى سي (2014).

4 - دراسه متعددة المراكز من المرحله الثانيه لعقار السورافينيب المانع ل بى راف - كيناز في مرضى سرطان الخلايا الكلوية المتقدمة (2015).

5 - CD25 عالية FoxP3 لخلايا تي التنظيمية في سرطان الدم الميلودى المزمن النموذجية والغير نموذجية موجبة الفيلادلفيا و علاقتها بالاستجابة للعلاج بالايميتنيب (2015).

6 - دراسة مستوى الإندوستاتين في بلازما مرضى سرطان الدم الميلودي الحاد (2015).

7 - القيمة التشخيصية لنسبة الهيماتوجونس في المرضى الذين يعانون من سرطان الدم االميلودى الحاد في أول استجابه كاملة. (2015).

8 - هل المرضى المصريين يعرفون تشخيص اصابتهم بالسرطان ؟ (2015).

9 - Rituximab-induced hepatitis C virus reactivation in HCV-positive patients with diffuse large B-cell lymphoma (2016).

10 - Safety and Efficacy of Biweekly Cetuximab Based Chemotherapy for Patients with Metastatic Colorectal Cancer (2016).

11 - Study of Plasma Endostatin Level in Patients with Acute Myeloid Leukemia (2016).

12 - Prognostic Value of Snail-1and Beta-Catenin Immunostaining in Astrocytoma (2016).

13 - Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units (2016).

14 - Prognostic Implication of MYSM-1 and Twist-1 in Renal Cell Carcinoma (2016).

15 - CD56 and CD19 Antigens Expression in Acute Myeloid Leukemia Identifies Patients with Adverse Prognosis in Egypt (2016).

16 - Prognostic impact of 25-hydroxyvitamin D levels in Egyptian patients with breast cancer (2015).

17 - Prognostic Value of Hematogones in Patients with Acute Myeloid Leukemia in First Complete Remission (2015).

18 - Clinicopathologic features and pattern of care of renal cell carcinoma: A retrospective study from Egypt. (2015).

19 - Assessment of initial real life experience with Abiraterone Acetate in patients with castrate resistant prostate cancer: A retrospective study in Saudi Arabian patients (2015).

20 - Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer (2015).

21 - Clinicopathological features of breast cancer molecular subtypes in ‎Egyptian women reside at Sharkia governorate‎ (2014).

22 - Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial - An update (2014).

23 - The outcome of acute myeloid leukemia presenting with leucopenia: A retrospective study (2013).

24 - Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial (2011).

25 - Whole-body FSE STIR MR imaging of lymphoma (2011).

26 - Gene expression profile of advanced squamous and transitional cell carcinoma of the bladder (2010).

27 - Study of vascular endothelial growth factor (VEGF) and vascular cell adhesion molecule-1(VCAM-1)in metastatic breast cancer (MBC) and response to weekly docetaxel protocol (2005).

28 - Prognostic Value of Snail-1and Beta-Catenin Immunostaining in Astrocytoma. (2016).

29 - Immunohistochemical expressions of SQSTM1/p62, Beclin-1, and SOX4 in infiltrating duct carcinoma of the breast (2016).

30 - Prognostic implication of MYb-like, swirm and Mpn domain-containing protein-1 and Twist-1 in renal cell carcinoma (2017).

31 - Prognostic Value of Snail-1and Beta-Catenin Immunostaining in Astrocytoma (2016).

32 - The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma (2017).

33 - Prognostic Impact of 25-Hydroxyvitamin D Levels in Egyptian Patients with Breast Cancer (2017).

34 - Hepatitis C virus and non-Hodgkin’s lymphomas: A minireview (2017).

35 - The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma (2017).

36 - Factors Affecting Survival in Egyptian Patients Suffering from Urinary Bladder Cancer: A Multicenter Retrospective Study (2018).

37 - Awareness of Diagnosis in Patients with Cancer: A Study from Egypt (2016).

38 - A prospective Multicenter Study of primary breast lymphoma in Rutiximab Era: Prognostic Implication of Beta-2 microglobulin and interleukins-6 (2017).

39 - Clinicopathologic features and pattern of care of renal cell carcinoma: A retrospective study from Egypt (2015).

40 - Prognostic Significance of VEGF and HIF 1 α in Hepatocellular Carcinoma Patients receiving sorafenib versus metformin sorafenib combination" (2017).

41 - Clinicopathological Significance Of Cancer Stem Cells (Cd 44 And Cd133) And Inflammatory Microenvironment (Tams And Mast Cells) In Colorectal Cancer: Immunohistochemical Study. (2016).

42 - Prognostic role of H3K9 methyltransferase G9a and Sprouty 1 in colorectal carcinoma. (2016).

43 - Prognostic value of Serum Cripto-1 in patients with non-small cell lung (2016).

44 - Safety and efficacy of biweekly cetuximab based chemotherapy for patients with metastatic colorectal cancer (2016).

45 - Safety and efficacy of biweekly cetuximab based chemotherapy for patients with metastatic colorectal cancer (2016).

46 - Ultrasound elastography in pathological enlarged cervical lymph nodes compared to histopathology. Egyptian Journal of Radiology and Nuclear Medicine (2016).

47 - Predictive and prognostic value of SALL4 and Tau protein in Serous Ovarian Cancer patients treated with chemotherapy (2016).

48 - Study of Plasma Endostatin Level in Patients with Acute Myeloid Leukemia (2016).

49 - Prognostic Value of Immunohistochemical Expressions of the Stem Cell Biomarker "LGR5" and the Proliferation Biomarker "TPX2" in Colorectal Carcinoma (2016).

50 - Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units (2016).

51 - Rituximab-Induced Hepatitis C Virus Reactivation in HCV-positive patients with diffuse large B-cell lymphoma (2016).

52 - Prognostic Implication of MYb-Like, Swirm and Mpn Domain-Containing Protein-1 and Twist-1 in Renal Cell Carcinoma (2016).

53 - Response to two treatment regimens in adult Egyptian patients with Burkitt’s lymphoma (2015).

54 - Prognostic Impact of microRNAs (miR-155, miR-10a, let-7a) on the Outcome of Adult Patients with Acute Myeloid Leukemia. (2019).

55 - Role of Neoadjuvant Chemotherapy on the Surgical Treatment of Locally Advanced Breast Cancer (2019).

56 - Significance of Combined Analysis of PARP1 and EZH2 Expression as Potentially Targetable Biomarkers in Breast Cancer (2018).

57 - Prognostic significance of CXCR4 and mTOR expression in diffuse large B-cell lymphoma patients (2019).

58 - prospective multicenter study of primary breast lymphoma in the rituximab era: Prognostic implication of beta 2 microglobulin and interlukin-6 & interlukin-10 (2018).

59 - Factors Affecting Survival in Egyptian Patients Suffering from Urinary Bladder Cancer: A Multicenter Retrospective Study (2018).

60 - The Value of HER2 neu and EphA2 expressions in Gastric Adenocarcinoma Prognosis (2017).

61 - Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination (2020).

62 - Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib (2022).

63 - Diagnosis of Sepsis among Adult Patients with AML Using Scd14 (2021).

64 - Prognostic Impact of microRNAs (miR-155, miR-10a, let-7a) on the Outcome of Adult Patients with Acute Myeloid Leukemia. (2021).

65 - Relation between Vitamin D Level and Severity of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients (2024).

66 - Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Diffuse Large B Cell Lymphoma Patients Treated with RCHOP (2024).

67 - Assessment of Body Mass Index As Prognostic Parameter In Management Of Metastatic Colorectal Cancer. Journal of Pharmaceutical Negative Results (2023).

68 - THE PROGNOSTIC VALUE OF ANDROGEN RECEPTOR EXPRESSION IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS (2022).

69 - Phe354Leu polymorphism of the liver kinase B1 gene as a prognostic factor in adult egyptian patients with acute myeloid leukemia (2023).

70 - Anti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer (2023).

71 - Advances in Diagnosis and Management of Acute Myeloid Leukemia (2023).

72 - Value of the Preoperative Prognostic Nutritional Index in Ovarian Cancer (2024).

73 - Outcomes of surgical resection of pancreatic cystic neoplasms based on the european expert consensus statement: A prospective observational study (2022).

74 - Assessment Of Body Mass Index As Prognostic Parameter In Management Of Metastatic Colorectal Cancer (2023).

75 - Abnormalities Of Chromosome 17 In Patients With Myeloid Malignancies (2022).

Research Area